A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma

Area of Science:

• Oncology
• Biotechnology
• Biomaterials Science

Background:

• Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with limited preclinical models accurately reflecting its tumor microenvironment.
• Developing reliable models is crucial for advancing cancer research and therapeutic strategies.

Purpose of the Study:

• To develop a 3D bioprinted tumor model that mimics the heterogeneous microenvironment of metastatic pancreatic ductal adenocarcinoma.
• To assess the viability, proliferation, and self-organization of cancer cells within the 3D bioprinted construct.

Main Methods:

• Utilized extrusion 3D bio-printing to create a model with pancreatic cancer cells (Panc-1) and cancer-associated fibroblasts (CAFs).
• Encapsulated cells within a sodium alginate and gelatin-based hydrogel to mimic the tumor microenvironment.
• Attempted to vascularize the model and characterized its structural and cellular properties.

Main Results:

• The 3D bioprinted tumor model demonstrated sustained cell viability and proliferation.
• Cells self-organized into heterogeneous aggregates within the hydrogel construct.
• The model successfully mimicked aspects of the metastatic PDAC microenvironment.

Conclusions:

• 3D bio-printing offers a promising approach for creating complex and reproducible cancer tumor models.
• This bioprinted pancreatic cancer model serves as a versatile platform for future anti-cancer therapy research.
• Further development could enhance the model's utility in preclinical drug testing and understanding tumor biology.